Yuval Cohen, Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP), sold 55,266 shares at $17.01 ($942K) on 2025-10-24, disclosed to the SEC on 2025-10-27.
Scheduled sale ($942k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.01 | 18,660 | $317K | 33.7% |
| 2 | $17.01 | 18,660 | $317K | 33.7% |
| 3 | $17.14 | 8,973 | $154K | 16.3% |
| 4 | $17.14 | 8,973 | $154K | 16.3% |
| Total | $17.05 avg | 55,266 | $942K | 100% |
| Filing → |
| CRBP | SELL | 2025-02-18 | $125K | — | Filing → |
| CRBP | SELL | 2024-06-18 | $5.9M | — | Filing → |
| CRBP | BUY | 2022-08-11 | $988 | — | Filing → |